Janus Henderson Group plc 13D and 13G filings for ARCA biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-05 5:20 pm Purchase | 2024-07-02 | 13G | ARCA biopharma, Inc. ABIO | JANUS HENDERSON GROUP PLC JHG | 123,545 10.200% | 33,536 (+37.26%) | Filing |
| 2024-04-11 09:51 am Purchase | 2024-04-03 | 13G | ARCA biopharma, Inc. ABIO | JANUS HENDERSON GROUP PLC JHG | 90,009 7.400% | 90,009 (New Position) | Filing |